Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,47%
1 067,36
+4,96
+0,47%
—1 062,401 064,141 071,991 061,02——
SIXC
Communications
SIXC
Communications
SIXC
-0,54%
603,48
-3,26
-0,54%
—606,74606,74609,84602,33——
SIXE
Energy
SIXE
Energy
SIXE
+0,54%
1 244,93
+6,72
+0,54%
—1 238,211 236,601 247,741 232,10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,68%
1 730,38
+11,77
+0,68%
—1 718,611 723,231 741,481 717,47——
SIXM
Financials
SIXM
Financials
SIXM
+0,33%
639,47
+2,10
+0,33%
—637,37638,27642,30638,27——
SIXR
Staples
SIXR
Staples
SIXR
+0,16%
854,95
+1,36
+0,16%
—853,59854,05858,19851,34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,11%
218,56
+0,23
+0,11%
—218,33218,33219,73217,15——
SIXT
Technology
SIXT
Technology
SIXT
+1,02%
3 631,59
+36,78
+1,02%
—3 594,813 620,103 657,473 615,34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,80%
915,77
+7,23
+0,80%
—908,54909,50917,35907,07——
SIXV
Health care
SIXV
Health care
SIXV
+1,19%
1 512,81
+17,81
+1,19%
—1 495,001 499,611 517,101 499,61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,41%
2 408,21
+9,90
+0,41%
—2 398,312 406,822 421,802 404,22——
1093:HKG
CSPC Pharmaceutical Group Ltd
7,44 HK$
-3,25%
(-0,25) 1D
26 մյս, 16:08:21 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1093...
Open
7,77 HK$
High
7,77 HK$
Low
7,38 HK$
Mkt. cap
85,73 մլրդ
Avg. vol.
75,10 մլն
Volume
77,23 մլն
Dividend
3,90%
Quarterly dividend
0,07 HK$
Ex-dividend date
24 հնս, 2026 թ.
P/E ratio
19,01
52-wk high
11,63 HK$
52-wk low
6,45 HK$
EPS
0,39 HK$
Shares outstanding
11,52 մլրդ
No. of employees
20 հզր
News stories
From sources across the web
Profile
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province. CSPC produces both active pharmaceutical ingredient and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products. CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP. CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion. CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” Wikipedia
About CSPC Pharmaceutical Group Ltd
CEOZhang Cuilong
Employees19,7 հզր
Founded1992
Headquarters-
Sector-
Websitecspc.com.hk
Last report
25 մրտ, 2026 թ.
Fiscal period
Q4 2025
EPS / Est. (HKD)
- / -
Revenue / Est. (HKD)
6,94 մլրդ / 8,72 մլրդ
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in HKD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
7,01 մլրդ
6,26 մլրդ
6,62 մլրդ
6,11 մլրդ
Cost of goods sold
2,31 մլրդ
2,25 մլրդ
2,28 մլրդ
2,11 մլրդ
Cost of revenue
2,31 մլրդ
2,25 մլրդ
2,28 մլրդ
2,11 մլրդ
Research and development expenses
1,30 մլրդ
1,38 մլրդ
1,50 մլրդ
1,62 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,89 մլրդ
1,56 մլրդ
1,97 մլրդ
1,87 մլրդ
Operating expense
3,19 մլրդ
2,94 մլրդ
3,47 մլրդ
3,49 մլրդ
Total operating expenses
5,50 մլրդ
5,20 մլրդ
5,75 մլրդ
5,60 մլրդ
Operating income
1,51 մլրդ
1,06 մլրդ
869,63 մլն
514,71 մլն
Other non operating income
278,47 մլն
3,60 մլն
645,49 մլն
-470,42 մլն
EBT including unusual items
1,80 մլրդ
1,32 մլրդ
1,18 մլրդ
505,59 մլն
EBT excluding unusual items
1,80 մլրդ
1,14 մլրդ
1,37 մլրդ
186,56 մլն
Income tax expense
301,26 մլն
242,36 մլն
222,47 մլն
165,64 մլն
Effective tax rate
16,77%
18,34%
18,78%
32,76%
Other operating expenses
-
-
-
-
Net income
1,48 մլրդ
1,07 մլրդ
963,54 մլն
370,72 մլն
Net profit margin
21,07%
17,09%
14,56%
6,06%
Earnings per share
-
-
-
-
Interest and investment income
-
95,00 մլն
-
195,87 մլն
Interest expense
-6,74 մլն
-14,91 մլն
-105,19 մլն
-6,76 մլն
Net interest expenses
-6,74 մլն
80,09 մլն
-105,19 մլն
189,12 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,79 մլրդ
1,36 մլրդ
1,14 մլրդ
802,06 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer